[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366420-105":59,"doc-detail-366420-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","emerging-biomarkers-for-early-cancer-detection-and-diagnosis-challenges-innovations-and-clinical-perspectives","Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives","","Early detection and accurate cancer diagnosis are crucial for improving patient outcomes and survival rates. This review synthesizes emerging biomarkers to enable non-invasive, efficient, and reliable identification of cancer in its early stages. It surveys advances in circulating tumor DNA (ctDNA), exosomes, liquid biopsies, microRNAs (miRNAs), and immunotherapy biomarkers, highlighting their promise for early detection. The review also addresses key barriers such as low ctDNA concentration and fragmentation, exosome isolation complexity, miRNA inter-patient variability, and the lack of clinical standardization, especially in low-resource settings.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-biomarkers-for-early-cancer-detection-and-diagnosis-challenges-innovations-and-clinical-perspectives/366420/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-biomarkers-for-early-cancer-detection-and-diagnosis-challenges-innovations-and-clinical-perspectives/366420.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is early cancer detection important?","Question",{"text":113,"@type":114},"Early diagnosis improves overall and recurrence-free survival, supports timely interventions, and can enable less invasive treatment options, leading to better patient outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which emerging biomarkers are discussed in this review?",{"text":118,"@type":114},"The review covers circulating tumor DNA (ctDNA), exosomes and liquid biopsies, microRNAs (miRNAs), and immunotherapy-related biomarkers.",{"name":120,"@type":111,"acceptedAnswer":121},"What are the main challenges limiting clinical use of these biomarkers?",{"text":122,"@type":114},"Key challenges include low ctDNA concentration and fragmentation, rapid clearance of ctDNA, complexity of exosome isolation, variability of miRNA expression between patients, and absence of clinical standardization.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},366420,1790197838,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","Zafar etal. European Journal  \nEuropean Journal of Medical Research (2025) 30:760  \n[https://doi.org/10.1186/s40001-025-03003-6](https://doi.org/10.1186/s40001-025-03003-6 of Medical Research)[ of Medical Research](https://doi.org/10.1186/s40001-025-03003-6 of Medical Research)  \n REVIEW Open Access  \nEmerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives  \nSameen Zafar1, Amna Hafeez 1, Hania Shah1, Iqra Mutiullah 1, Arslan Ali1, Khushbukhat Khan2*, Gabriela Figueroa‑González3, Octavio Daniel Reyes‑Hernández3, Laura Itzel Quintas‑Granados4, Sheila I. Peña‑Corona5, Lashyn N. Kiyekbayeva6*, Monica Butnariu7*, Cristina‑Elena Tota7, Angela Caunii8,9, Dietrich Büsselberg10, Javad Sharifi‑Rad11,12,13* and Gerardo Leyva‑Gómez5*  \nAbstract  \nEarly detection and accurate cancer diagnosis are crucial for improving patient outcomes and survival rates. This review presents a comprehensive and updated synthesis of emerging biomarkers, essential for providing non‑ invasive, efficient, and reliable methods to identify cancer in its early stages. An extensive literature review focuses on recent studies and advancements in both traditional and emerging biomarkers, including circulating tumor DNA (ctDNA), exosomes, liquid biopsies, microRNAs (miRNAs), and immunotherapy biomarkers, which show promis‑ ing potential for early cancer detection. Liquid biopsies, nanobiosensors, artificial intelligence, and next‑generation sequencing (NGS) are transforming biomarker discovery and application. Key challenges include low concentra‑ tion and fragmentation, as well as clearance of ctDNA, the complexity of exosome isolation, inter‑patient variability in miRNA expression, and the absence of clinical standardization. We also highlight the translational barriers in low‑ resource settings and suggest strategies for future implementation. We also underscore the limited diagnostic accessibility in low‑resource settings, emphasizing the importance of equity in future applications. Future research should prioritize overcoming current challenges, promoting multidisciplinary collaboration, and creating standardized protocols to enhance the clinical utility of this approach.  \nKeywords Biomarker, Cancer, Diagnosis, Exosomes, Expression, Immunotherapy, Liquid biopsy, MiRNA  \n*Correspondence: Khushbukhat Khan  \nkhan201 [1@hotmail.com](1@hotmail.com)  \nLashyn N. Kiyekbayeva[lashynk@mail. ru](lashynk@mail. ru)  \nMonica Butnariu [monicabutnariu@yahoo.com](monicabutnariu@yahoo.com)[ ](monicabutnariu@yahoo.com)Javad Sharifi‑Rad [javadsharifirad@uees.edu.ec](javadsharifirad@uees.edu.ec)[ ](javadsharifirad@uees.edu.ec)Gerardo Leyva‑Gómez [leyva@quimica. unam. mx](leyva@quimica. unam. mx)  \nFull list of author information is available at the end of the article  \nIntroduction  \nCancer has become one of the most fatal public health concerns throughout the globe. In 2022, there were 20 million new cases of cancer reported, along with 10 million cancer-associated deaths, making cancer the second leading cause of mortality [1].  \nEarly cancer diagnosis significantly increases patient outcomes by enhancing overall and recurrence-free survival rates [2, 3] . An investigation demonstrated that early detection led to a median overall survival of 38 months, compared to 14 months with delayed diagnosis. In addition, it raises quality of life scores from 55 to 75 and lowers severe treatment-related side effects  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this art","cbCainzQU7rvrE0x","https://ap.wps.com/l/cbCainzQU7rvrE0x","pdf",2679450,34,"English","# Abstract\n# Introduction\n## Cancer as a global health concern\n## Impact of early diagnosis\n## Challenges in low-income settings\n## Etiology and risk factors","[{\"question\":\"Why is early cancer detection important?\",\"answer\":\"Early diagnosis improves overall and recurrence-free survival, supports timely interventions, and can enable less invasive treatment options, leading to better patient outcomes.\"},{\"question\":\"Which emerging biomarkers are discussed in this review?\",\"answer\":\"The review covers circulating tumor DNA (ctDNA), exosomes and liquid biopsies, microRNAs (miRNAs), and immunotherapy-related biomarkers.\"},{\"question\":\"What are the main challenges limiting clinical use of these biomarkers?\",\"answer\":\"Key challenges include low ctDNA concentration and fragmentation, rapid clearance of ctDNA, complexity of exosome isolation, variability of miRNA expression between patients, and absence of clinical standardization.\"}]","Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives | PDF",1790165468,86,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de40e84b44f86a7121a90a16c6ebf342.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/475c6f4c0b8016ce0bbb23267711701e.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ddc376d0c631057fe390c6322f4fb3ef.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61f70390455ff8154a8cd465b1fa8fc4.webp",980,1301]